Aquestive announced its expected addition to the broad-market Russell 3000 and Russell 2000 Indexes at the conclusion of the 2024 Russell U.S. indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1, according to a preliminary list of additions posted Friday, May 24, 2024.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
- Aquestive Therapeutics Shares Investor Presentation Update
- Aquestive Therapeutics Appoints Cassie Jung as COO
- Aquestive Therapeutics appoints Cassie Jung as COO, Stephen Wargacki as CSO
- Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities